Chaar Abdelkader, Yoo Jin Woo, Nawaz Ahmad, Rizwan Rabia, Agha Osama Qasim, Feuerstadt Paul
Department of Internal Medicine, Yale School of Medicine, New Haven, CT (Abdelkader Chaar, Jin Woo Yoo, Rabia Rizwan).
Department of Medicine, Yale-New Haven Hospital, New Haven, CT (Abdelkader Chaar, Jin Woo Yoo, Rabia Rizwan).
Ann Gastroenterol. 2024 Jul-Aug;37(4):442-448. doi: 10.20524/aog.2024.0898. Epub 2024 Jun 20.
Frailty has major health implications for affected patients and is widely used in the perioperative risk assessment. The Hospital Frailty Risk Score (HFRS) is a validated score that utilizes administrative billing data to identify patients at higher risk because of frailty. We investigated the utility of the HFRS in patients with infection (CDI) to determine whether they were at risk for worse outcomes and higher healthcare resource utilization.
Using the 2017 National Inpatient Sample, we identified all adults with a primary diagnosis of CDI. We classified patients into 2 groups: those who had an HFRS <5 (NonFrailCDI) and those with a score ≥5 (FrailCDI). We assessed differences in hospital outcomes and healthcare resource utilization based on frailty status.
We identified 93,810 hospitalizations, of which 54,300 (57.88%) were FrailCDI. FrailCDI patients were at higher risk for fulminant CDI (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.6-2.3), requiring colectomy (OR 4.1, 95%CI 1.5-11.2), and inpatient mortality (OR 4.5, 95%CI 2.8-7.1). Furthermore, FrailCDI patients had higher odds of requiring Intensive Care Unit admission (OR 13.7, 95%CI 6.3-29.9) or transfer to another facility on discharge (OR 2.2, 95%CI 2.0-2.4), and had longer hospital stays and higher total charges when compared with NonFrailCDI.
Frailty as defined by the HFRS is an independent factor for worse outcomes and higher healthcare utilization in adults admitted for CDI. Risk stratifying patients by frailty may improve outcomes.
衰弱对受影响的患者具有重大健康影响,并且在围手术期风险评估中被广泛使用。医院衰弱风险评分(HFRS)是一种经过验证的评分系统,它利用行政计费数据来识别因衰弱而处于较高风险的患者。我们研究了HFRS在艰难梭菌感染(CDI)患者中的效用,以确定他们是否有不良结局和更高的医疗资源利用风险。
利用2017年全国住院患者样本,我们识别出所有以CDI为主要诊断的成年人。我们将患者分为两组:HFRS<5的患者(非衰弱CDI)和评分≥5的患者(衰弱CDI)。我们根据衰弱状态评估医院结局和医疗资源利用的差异。
我们识别出93810例住院病例,其中54300例(57.88%)为衰弱CDI。衰弱CDI患者发生暴发性CDI的风险更高(比值比[OR]1.9,95%置信区间[CI]1.6 - 2.3),需要进行结肠切除术(OR 4.1,95%CI 1.5 - 11.2),以及住院死亡率(OR 4.5,95%CI 2.8 - 7.1)。此外,衰弱CDI患者入住重症监护病房的几率更高(OR 13.7,95%CI 6.3 - 29.9)或出院时转至另一机构的几率更高(OR 2.2,95%CI 2.0 - 2.4),与非衰弱CDI相比,住院时间更长,总费用更高。
HFRS所定义的衰弱是CDI住院成人不良结局和更高医疗利用的独立因素。根据衰弱对患者进行风险分层可能会改善结局。